Elevation Oncology IncNASDAQ:ELEVNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5418
- TODAY'S CHANGE (%)0.0192 (3.6739%)
- Bid / Lots0.5407/ 7
- Ask / Lots0.5649/ 7
- Open / Previous Close0.5300 / 0.5226
- Day Range
- 52 Week Range
- Volume507,624
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ELEV |
|---|---|---|
| 09:32 ET | 21075 | 0.5329 |
| 09:35 ET | 17105 | 0.5299 |
| 09:37 ET | 6065 | 0.532 |
| 09:42 ET | 1000 | 0.5348 |
| 09:46 ET | 2891 | 0.5333 |
| 09:48 ET | 100 | 0.5333 |
| 09:50 ET | 100 | 0.5336 |
| 09:53 ET | 5929 | 0.5363 |
| 09:55 ET | 600 | 0.5336 |
| 09:57 ET | 100 | 0.5363 |
| 10:00 ET | 100 | 0.5336 |
| 10:06 ET | 4597 | 0.544999 |
| 10:08 ET | 100 | 0.545 |
| 10:11 ET | 2000 | 0.54469 |
| 10:13 ET | 1033 | 0.543221 |
| 10:15 ET | 200 | 0.548 |
| 10:18 ET | 320 | 0.548 |
| 10:20 ET | 417 | 0.546 |
| 10:24 ET | 5890 | 0.5444 |
| 10:26 ET | 100 | 0.5411 |
| 10:27 ET | 100 | 0.5444 |
| 10:29 ET | 650 | 0.5413 |
| 10:33 ET | 499 | 0.5412 |
| 10:36 ET | 700 | 0.5412 |
| 10:42 ET | 1100 | 0.5476 |
| 10:44 ET | 200 | 0.5408 |
| 10:47 ET | 566 | 0.5442 |
| 10:49 ET | 100 | 0.5444 |
| 10:51 ET | 11727 | 0.5444 |
| 10:54 ET | 6106 | 0.54 |
| 11:02 ET | 2409 | 0.5399 |
| 11:03 ET | 144 | 0.535301 |
| 11:07 ET | 100 | 0.5358 |
| 11:12 ET | 200 | 0.53755 |
| 11:14 ET | 21012 | 0.5429 |
| 11:16 ET | 100 | 0.5428 |
| 11:18 ET | 6000 | 0.5359 |
| 11:21 ET | 100 | 0.5428 |
| 11:27 ET | 444 | 0.5411 |
| 11:30 ET | 100 | 0.5411 |
| 11:32 ET | 27133 | 0.5414 |
| 11:34 ET | 1083 | 0.5411 |
| 11:36 ET | 657 | 0.5405 |
| 11:39 ET | 271 | 0.5379 |
| 11:45 ET | 100 | 0.5425 |
| 11:48 ET | 49984 | 0.5425 |
| 11:50 ET | 1816 | 0.543 |
| 11:52 ET | 200 | 0.543 |
| 11:54 ET | 384 | 0.5449 |
| 12:06 ET | 1377 | 0.5448 |
| 12:12 ET | 231 | 0.54155 |
| 12:15 ET | 100 | 0.5437 |
| 12:19 ET | 1300 | 0.5437 |
| 12:26 ET | 200 | 0.5384 |
| 12:35 ET | 3300 | 0.5436 |
| 12:37 ET | 200 | 0.5397 |
| 12:42 ET | 5000 | 0.5417 |
| 12:44 ET | 300 | 0.5402 |
| 12:48 ET | 400 | 0.5402 |
| 12:50 ET | 200 | 0.5417 |
| 12:55 ET | 100 | 0.5437 |
| 01:00 ET | 1000 | 0.5437 |
| 01:02 ET | 1749 | 0.5436 |
| 01:04 ET | 15455 | 0.5436 |
| 01:06 ET | 100 | 0.543 |
| 01:08 ET | 10900 | 0.5405 |
| 01:09 ET | 9576 | 0.5429 |
| 01:11 ET | 1754 | 0.5404 |
| 01:13 ET | 1200 | 0.5397 |
| 01:27 ET | 100 | 0.5383 |
| 01:33 ET | 100 | 0.5397 |
| 01:36 ET | 200 | 0.5423 |
| 01:42 ET | 695 | 0.5398 |
| 01:44 ET | 100 | 0.5423 |
| 01:45 ET | 280 | 0.5398 |
| 01:47 ET | 600 | 0.5429 |
| 01:56 ET | 3400 | 0.5404 |
| 01:58 ET | 899 | 0.5405 |
| 02:00 ET | 1318 | 0.5404 |
| 02:02 ET | 548 | 0.5404 |
| 02:03 ET | 100 | 0.5448 |
| 02:05 ET | 400 | 0.5406 |
| 02:07 ET | 798 | 0.5406 |
| 02:09 ET | 500 | 0.5413 |
| 02:12 ET | 800 | 0.5405 |
| 02:14 ET | 388 | 0.5403 |
| 02:16 ET | 100 | 0.5403 |
| 02:25 ET | 200 | 0.5448 |
| 02:27 ET | 5400 | 0.5448 |
| 02:30 ET | 800 | 0.5417 |
| 02:32 ET | 7762 | 0.545 |
| 02:36 ET | 397 | 0.5389 |
| 02:38 ET | 600 | 0.539 |
| 02:39 ET | 600 | 0.5367 |
| 02:41 ET | 400 | 0.5365 |
| 02:43 ET | 979 | 0.538 |
| 02:45 ET | 662 | 0.5353 |
| 02:48 ET | 7507 | 0.5355 |
| 02:50 ET | 1300 | 0.5384 |
| 02:52 ET | 399 | 0.5355 |
| 02:54 ET | 300 | 0.5355 |
| 02:56 ET | 1747 | 0.5354 |
| 02:57 ET | 424 | 0.5353 |
| 02:59 ET | 200 | 0.535 |
| 03:01 ET | 5400 | 0.5381 |
| 03:03 ET | 850 | 0.5381 |
| 03:06 ET | 300 | 0.5351 |
| 03:08 ET | 691 | 0.5366 |
| 03:10 ET | 600 | 0.5352 |
| 03:12 ET | 3759 | 0.536549 |
| 03:15 ET | 5327 | 0.5363 |
| 03:17 ET | 300 | 0.538 |
| 03:19 ET | 600 | 0.536 |
| 03:21 ET | 300 | 0.536 |
| 03:24 ET | 200 | 0.5382 |
| 03:26 ET | 399 | 0.5381 |
| 03:28 ET | 500 | 0.5376 |
| 03:30 ET | 3800 | 0.5397 |
| 03:32 ET | 888 | 0.5372 |
| 03:33 ET | 11627 | 0.5374 |
| 03:35 ET | 1898 | 0.5378 |
| 03:37 ET | 1394 | 0.5373 |
| 03:39 ET | 6231 | 0.5368 |
| 03:42 ET | 400 | 0.5362 |
| 03:44 ET | 932 | 0.5369 |
| 03:46 ET | 600 | 0.5389 |
| 03:48 ET | 2312 | 0.541 |
| 03:50 ET | 13146 | 0.5394 |
| 03:51 ET | 2600 | 0.5381 |
| 03:53 ET | 6100 | 0.5401 |
| 03:55 ET | 1800 | 0.54 |
| 03:57 ET | 7543 | 0.5362 |
| 04:00 ET | 92075 | 0.5418 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Elevation Oncology Inc | 30.9M | -0.6x | --- |
Ocean Biomedical Inc | 31.2M | -0.3x | --- |
Impact Biomedical Inc | 31.3M | -7.3x | --- |
LianBio | 31.3M | -0.4x | --- |
Acurx Pharmaceuticals Inc | 30.1M | -1.6x | --- |
Iterum Therapeutics PLC | 30.0M | -0.6x | --- |
Company Information
Elevation Oncology, Inc. is an oncology company. The Company is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. EO-3021 consists of a fully human immunoglobulin G1 (IgG1) mAb that targets Claudin 18.2 and is site-specifically conjugated to the monomethyl auristatin E (MMAE) payload via a cleavable linker with a drug-to-antibody ratio (DAR) of 2. EO-3021 is designed to bind to Claudin 18.2 on the cell surface and is internalized, upon which the linker is cleaved in the lysosome to release the MMAE payload, a potent anti-mitotic agent. Its second program is an ADC designed to target HER3, which is overexpressed across solid tumors.
Contact Information
- Headquarters
- 101 Federal Street, Suite 1900BOSTON, MA, United States 02110
- Phone
- 716-371-1125
- Fax
- 302-697-4597
Executives
- Chairman of the Board
- Steven Elms
- President, Chief Executive Officer, Director
- Joseph Ferra
- Chief Financial Officer
- Tammy Furlong
- Chief Scientific Officer
- David Dornan
- Chief Medical Officer
- Valerie Jansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $30.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 59.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-0.84 |
Book Value | $1.29 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
